Research Article
BibTex RIS Cite

Management of incidental dermatofibrosarcoma protuberans: A single center 5-year experience

Year 2020, Volume: 11 Issue: 5, 366 - 371, 30.12.2020
https://doi.org/10.18663/tjcl.823675

Abstract

Aim: Dermatofibrosarcoma protuberans (DFSP) is a rare skin tumor. The diagnosis is challenging because it is usually hard to differ DFSP from other skin lesions. Distant metastasis is rare, but local recurrence is common.The aim of this study is to review the treatment algorithms in DFSPs that are detected incidentally and to increase awareness about this rare tumor.
Material and Methods: 17 patients who underwent excision of epidermal lesions which were considered to be benign and were diagnosed with DFSP, at departmant of general surgery between 2012 and 2017, were analyzed.
Result: A total of 17 patients were analyzed retrospectively. No recurrence was detected in any of ourpatients.
Conclusion: Awareness of this rare entity is important for diagnosis and management of the disease.

References

  • Referans 1 Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data--a study from the French Federation of Cancer Centers Sarcoma Group Marie-Josée Terrier-Lacombe 1 , Louis Guillou, Georges Maire, Philippe Terrier, Dominique Ranchère Vince, Nicolas de Saint Aubain Somerhausen, Françoise Collin, Florence Pedeutour, Jean-Michel Coindre
  • Referans 2 Genomic and transcriptomic features of dermatofibrosarcoma protuberans: Unusual chromosomal origin of the COL1A1-PDGFB fusion gene and synergistic effects of amplified regions in tumor development a,b,∗ a c c a Jan Köster , Elsa Arbajian , Björn Viklund , Anders Isaksson , Jakob Hofvander , d e a a a,b Felix Haglund , Henrik Bauer , Linda Magnusson , Nils Mandahl , Fredrik Mertens

Insidental olarak saptanan dermatofibrosarkom protuberans tedavisi: Tek merkez 5 yıllık deneyimlerimiz

Year 2020, Volume: 11 Issue: 5, 366 - 371, 30.12.2020
https://doi.org/10.18663/tjcl.823675

Abstract

Aim: Dermatofibrosarcoma protuberans (DFSP) is a rare skin tumor. The diagnosis is challenging because it is usually hard to differ DFSP from other skin lesions. Distant metastasis is rare, but local recurrence is common.The aim of this study is to review the treatment algorithms in DFSPs that are detected incidentally and to increase awareness about this rare tumor.
Material and Methods: 17 patients who underwent excision of epidermal lesions which were considered to be benign and were diagnosed with DFSP, at departmant of general surgery between 2012 and 2017, were analyzed.
Result: A total of 17 patients were analyzed retrospectively. No recurrence was detected in any of ourpatients.
Conclusion: Awareness of this rare entity is important for diagnosis and management of the disease.

References

  • Referans 1 Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data--a study from the French Federation of Cancer Centers Sarcoma Group Marie-Josée Terrier-Lacombe 1 , Louis Guillou, Georges Maire, Philippe Terrier, Dominique Ranchère Vince, Nicolas de Saint Aubain Somerhausen, Françoise Collin, Florence Pedeutour, Jean-Michel Coindre
  • Referans 2 Genomic and transcriptomic features of dermatofibrosarcoma protuberans: Unusual chromosomal origin of the COL1A1-PDGFB fusion gene and synergistic effects of amplified regions in tumor development a,b,∗ a c c a Jan Köster , Elsa Arbajian , Björn Viklund , Anders Isaksson , Jakob Hofvander , d e a a a,b Felix Haglund , Henrik Bauer , Linda Magnusson , Nils Mandahl , Fredrik Mertens
There are 2 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Orıgınal Artıcle
Authors

Serdar Culcu

Ezgi Altinsoy This is me

Cemil Yuksel This is me

Ogün Erşen

Lutfi Dogan This is me

Publication Date December 30, 2020
Published in Issue Year 2020 Volume: 11 Issue: 5

Cite

APA Culcu, S., Altinsoy, E., Yuksel, C., Erşen, O., et al. (2020). Management of incidental dermatofibrosarcoma protuberans: A single center 5-year experience. Turkish Journal of Clinics and Laboratory, 11(5), 366-371. https://doi.org/10.18663/tjcl.823675
AMA Culcu S, Altinsoy E, Yuksel C, Erşen O, Dogan L. Management of incidental dermatofibrosarcoma protuberans: A single center 5-year experience. TJCL. December 2020;11(5):366-371. doi:10.18663/tjcl.823675
Chicago Culcu, Serdar, Ezgi Altinsoy, Cemil Yuksel, Ogün Erşen, and Lutfi Dogan. “Management of Incidental Dermatofibrosarcoma Protuberans: A Single Center 5-Year Experience”. Turkish Journal of Clinics and Laboratory 11, no. 5 (December 2020): 366-71. https://doi.org/10.18663/tjcl.823675.
EndNote Culcu S, Altinsoy E, Yuksel C, Erşen O, Dogan L (December 1, 2020) Management of incidental dermatofibrosarcoma protuberans: A single center 5-year experience. Turkish Journal of Clinics and Laboratory 11 5 366–371.
IEEE S. Culcu, E. Altinsoy, C. Yuksel, O. Erşen, and L. Dogan, “Management of incidental dermatofibrosarcoma protuberans: A single center 5-year experience”, TJCL, vol. 11, no. 5, pp. 366–371, 2020, doi: 10.18663/tjcl.823675.
ISNAD Culcu, Serdar et al. “Management of Incidental Dermatofibrosarcoma Protuberans: A Single Center 5-Year Experience”. Turkish Journal of Clinics and Laboratory 11/5 (December 2020), 366-371. https://doi.org/10.18663/tjcl.823675.
JAMA Culcu S, Altinsoy E, Yuksel C, Erşen O, Dogan L. Management of incidental dermatofibrosarcoma protuberans: A single center 5-year experience. TJCL. 2020;11:366–371.
MLA Culcu, Serdar et al. “Management of Incidental Dermatofibrosarcoma Protuberans: A Single Center 5-Year Experience”. Turkish Journal of Clinics and Laboratory, vol. 11, no. 5, 2020, pp. 366-71, doi:10.18663/tjcl.823675.
Vancouver Culcu S, Altinsoy E, Yuksel C, Erşen O, Dogan L. Management of incidental dermatofibrosarcoma protuberans: A single center 5-year experience. TJCL. 2020;11(5):366-71.


e-ISSN: 2149-8296

The content of this site is intended for health care professionals. All the published articles are distributed under the terms of

Creative Commons Attribution Licence,

which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.